Detection of occult metastasis in patients with breast cancer

Debra Hawes, A. Munro Neville, Richard J Cote

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The most important factor affecting the outcome of patients with invasive cancer is whether the tumor has spread, either regionally (to regional lymph nodes) or systemically. However, a proportion of patients with no evidence of systemic dissemination will develop recurrent disease after primary "curative" therapy. Clearly, these patients had occult systemic spread of disease that was undetectable by routinely employed methods (careful pathological, clinical, biochemical, and radiological evaluation). In addition, the success of adjuvant therapy is assumed to stem from its ability to eradicate occult metastases before they become clinically evident [1]. Therefore, methods for the detection of occult metastases in patients with the earliest stage of cancer, i.e., prior to detection of metastases by any other clinical or pathological analysis, have received a great deal of attention.

Original languageEnglish
Pages (from-to)312-318
Number of pages7
JournalSeminars in Surgical Oncology
Volume20
Issue number4
DOIs
StatePublished - Nov 20 2001
Externally publishedYes

Fingerprint

Breast Neoplasms
Neoplasm Metastasis
Neoplasms
Lymph Nodes
Therapeutics

Keywords

  • Bone marrow
  • Breast cancer
  • Lymph nodes
  • Occult metastases
  • Prognosis

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Detection of occult metastasis in patients with breast cancer. / Hawes, Debra; Neville, A. Munro; Cote, Richard J.

In: Seminars in Surgical Oncology, Vol. 20, No. 4, 20.11.2001, p. 312-318.

Research output: Contribution to journalArticle

Hawes, Debra ; Neville, A. Munro ; Cote, Richard J. / Detection of occult metastasis in patients with breast cancer. In: Seminars in Surgical Oncology. 2001 ; Vol. 20, No. 4. pp. 312-318.
@article{891e60d7f0664eadb07e07bd9c9e2d9c,
title = "Detection of occult metastasis in patients with breast cancer",
abstract = "The most important factor affecting the outcome of patients with invasive cancer is whether the tumor has spread, either regionally (to regional lymph nodes) or systemically. However, a proportion of patients with no evidence of systemic dissemination will develop recurrent disease after primary {"}curative{"} therapy. Clearly, these patients had occult systemic spread of disease that was undetectable by routinely employed methods (careful pathological, clinical, biochemical, and radiological evaluation). In addition, the success of adjuvant therapy is assumed to stem from its ability to eradicate occult metastases before they become clinically evident [1]. Therefore, methods for the detection of occult metastases in patients with the earliest stage of cancer, i.e., prior to detection of metastases by any other clinical or pathological analysis, have received a great deal of attention.",
keywords = "Bone marrow, Breast cancer, Lymph nodes, Occult metastases, Prognosis",
author = "Debra Hawes and Neville, {A. Munro} and Cote, {Richard J}",
year = "2001",
month = "11",
day = "20",
doi = "10.1002/ssu.1049",
language = "English",
volume = "20",
pages = "312--318",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Detection of occult metastasis in patients with breast cancer

AU - Hawes, Debra

AU - Neville, A. Munro

AU - Cote, Richard J

PY - 2001/11/20

Y1 - 2001/11/20

N2 - The most important factor affecting the outcome of patients with invasive cancer is whether the tumor has spread, either regionally (to regional lymph nodes) or systemically. However, a proportion of patients with no evidence of systemic dissemination will develop recurrent disease after primary "curative" therapy. Clearly, these patients had occult systemic spread of disease that was undetectable by routinely employed methods (careful pathological, clinical, biochemical, and radiological evaluation). In addition, the success of adjuvant therapy is assumed to stem from its ability to eradicate occult metastases before they become clinically evident [1]. Therefore, methods for the detection of occult metastases in patients with the earliest stage of cancer, i.e., prior to detection of metastases by any other clinical or pathological analysis, have received a great deal of attention.

AB - The most important factor affecting the outcome of patients with invasive cancer is whether the tumor has spread, either regionally (to regional lymph nodes) or systemically. However, a proportion of patients with no evidence of systemic dissemination will develop recurrent disease after primary "curative" therapy. Clearly, these patients had occult systemic spread of disease that was undetectable by routinely employed methods (careful pathological, clinical, biochemical, and radiological evaluation). In addition, the success of adjuvant therapy is assumed to stem from its ability to eradicate occult metastases before they become clinically evident [1]. Therefore, methods for the detection of occult metastases in patients with the earliest stage of cancer, i.e., prior to detection of metastases by any other clinical or pathological analysis, have received a great deal of attention.

KW - Bone marrow

KW - Breast cancer

KW - Lymph nodes

KW - Occult metastases

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=0034768116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034768116&partnerID=8YFLogxK

U2 - 10.1002/ssu.1049

DO - 10.1002/ssu.1049

M3 - Article

VL - 20

SP - 312

EP - 318

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 4

ER -